QIAGEN Makes Proposal to Acquire Australian Diagnostics Company Cellestis Limited
VENLO, Netherlands and MELBOURNE, Australia, April 3, 2011 /PRNewswire/ — — QIAGEN to acquire Cellestis Limited (CST:AU) via a Scheme of Arrangement (the Scheme) for approximately A$341 million(1) (US$355 million), or A$3.55 per share …